These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin. Slaga TJ; Gleason GL; DiGiovanni J; Sukumaran KB; Harvey RG Cancer Res; 1979 Jun; 39(6 Pt 1):1934-6. PubMed ID: 109189 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Scribner JD; Scribner NK; McKnight B; Mottet NK Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Verma AK; Garcia CT; Ashendel CL; Boutwell RK Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052 [TBL] [Abstract][Full Text] [Related]
5. High tumorigenicity of the 3,4-dihydrodiol of 7-methylbenz[c]acridine on mouse skin and in newborn mice. Chang RL; Levin W; Wood AW; Shirai N; Ryan AJ; Duke CC; Jerina DM; Holder GM; Conney AH Cancer Res; 1986 Sep; 46(9):4552-5. PubMed ID: 3731110 [TBL] [Abstract][Full Text] [Related]
6. Skin tumor initiating activities of the 9- and 10-fluoro derivatives of 7- or 12-methylbenz[a]anthracene and the 9- and 10-trifluoromethyl derivatives of 7,12-dimethylbenz[a]anthracene in SENCAR mice. Sawyer TW; Fisher EP; DiGiovanni J Carcinogenesis; 1987 Oct; 8(10):1465-8. PubMed ID: 3115616 [TBL] [Abstract][Full Text] [Related]
7. High stereoselectivity among the optical isomers of the diastereomeric bay-region diol-epoxides of benz(a)anthracene in the expression of tumorigenic activity in murine tumor models. Levin W; Chang RL; Wood AW; Yagi H; Thakker DR; Jerina DM; Conney AH Cancer Res; 1984 Mar; 44(3):929-33. PubMed ID: 6692415 [TBL] [Abstract][Full Text] [Related]
8. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols. Iversen OH APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481 [TBL] [Abstract][Full Text] [Related]
9. Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz(a)anthracene. Huberman E; Slaga TJ Cancer Res; 1979 Feb; 39(2 Pt 1):411-4. PubMed ID: 104789 [No Abstract] [Full Text] [Related]
10. Tumor initiating activity of 9- and 10-fluoro-7,12-dimethylbenz[a]-anthracene (DMBA) and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on tumor initiation by monofluoro derivatives of DMBA in SENCAR mice. DiGiovanni J; Decina PC; Diamond L Carcinogenesis; 1983 Aug; 4(8):1045-9. PubMed ID: 6409443 [TBL] [Abstract][Full Text] [Related]
11. [Effect of 7,12-dimethylbenz(alpha)anthracene metabolites on its capacity to induce skin tumors in mice]. Lopp LKh; Belitskiĭ GA Vopr Onkol; 1975; 21(10):50-5. PubMed ID: 810968 [TBL] [Abstract][Full Text] [Related]
12. The effect of fluoro substituents on reactivity of 7-methylbenz[a]anthracene diol epoxides. Baer-Dubowska W; Nair RV; Dubowski A; Harvey RG; Cortez C; DiGiovanni J Chem Res Toxicol; 1996 Jun; 9(4):722-8. PubMed ID: 8831816 [TBL] [Abstract][Full Text] [Related]
13. Protection of mice against 7,12-dimethylbenz(a)anthracene-induced skin tumors by immunization with a fluorinated analog of the carcinogen. Moolten FL; Schreiber B; Rizzone A; Weiss AJ; Boger E Cancer Res; 1981 Feb; 41(2):425-9. PubMed ID: 6778608 [TBL] [Abstract][Full Text] [Related]
14. Comparison of two-stage epidermal carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene or N-methyl-N'-nitro-N-nitrosoguanidine in newborn and adult SENCAR and BALB/c mice. Hennings H; Devor D; Wenk ML; Slaga TJ; Former B; Colburn NH; Bowden GT; Elgjo K; Yuspa SH Cancer Res; 1981 Mar; 41(3):773-9. PubMed ID: 6780187 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the tumor-initiating ability of the potent carcinogen 7,12-dimethylbenz(a)anthracene by the weak tumor initiator 1,2,3,4-dibenzanthracene. Slaga TJ; Boutwell RK Cancer Res; 1977 Jan; 37(1):128-33. PubMed ID: 401469 [TBL] [Abstract][Full Text] [Related]
16. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice. DiGiovanni J; Diamond L; Singer JM; Daniel FB; Witiak DT; Slaga TJ Carcinogenesis; 1982; 3(6):651-5. PubMed ID: 6811143 [TBL] [Abstract][Full Text] [Related]
17. The effect of steric strain in the bay-region of polycyclic aromatic hydrocarbons: tumorigenicity of alkyl-substituted benz[a]anthracenes. Levin W; Wood AW; Chang RL; Newman MS; Thakker DR; Conney AH; Jerina DM Cancer Lett; 1983 Sep; 20(2):139-46. PubMed ID: 6421476 [TBL] [Abstract][Full Text] [Related]
18. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12-dimethylbenz(a)anthracene and its 9- and 10-monofluoroderivatives in mice. DiGiovanni J; Sawyer TW; Fisher EP Cancer Res; 1986 Sep; 46(9):4336-41. PubMed ID: 3089589 [TBL] [Abstract][Full Text] [Related]
19. Tumor-initiating activity of benz[c]acridine and twelve of its derivatives on mouse skin. Levin W; Wood AW; Chang RL; Kumar S; Yagi H; Jerina DM; Lehr RE; Conney AH Cancer Res; 1983 Oct; 43(10):4625-8. PubMed ID: 6883319 [TBL] [Abstract][Full Text] [Related]
20. Comparative tumor-initiating activity of methylated benzo(a)pyrene derivatives in mouse skin. Iyer RP; Lyga JW; Secrist JA; Daub GH; Slaga TJ Cancer Res; 1980 Apr; 40(4):1073-6. PubMed ID: 7357537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]